1. Borukhov I, Rizzolo D. Overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease. JAAPA, 2016, 29(11): 18-22.
[2]
2. Khatri SB, Ioachimescu OC. The intersection of obstructive lung disease and sleep apnea. Cleve Clin J Med, 2016, 83(2): 127-140.
[3]
3. Soler X, Gaio E, Powell FL, et al. High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc, 2015, 12(8): 1219-1225.
[4]
4. Sanders MH, Newman AB, Haggerty CL, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med, 2003, 167(1): 7-14.
[5]
5. Bednarek M, Plywaczewski R, Jonczak L, et al. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration, 2005, 72(2): 142-149.
[6]
6. Basoglu OK, Gunduz C, Tasbakan MS. Prevalence of overlap syndrome in chronic obstructive pulmonary disease patients without sleep apnea symptoms. Clin Respir J, 2016 May 5. DOI: 10.1111/crj.12493. [Epub ahead of print].
[7]
7. Sharma B, Feinsilver S, Owens RL, et al. Obstructive airway disease and obstructive sleep apnea: effect of pulmonary function. Lung, 2011, 189(1): 37-41.
[8]
8. Hernández Voth A, Sayas Catalán J, Benavides Ma?as P, et al. Obstructive sleep apnea-hypopnea syndrome in patients with severe chronic respiratory insufficiency. Med Clin (Barc), 2017, 148(10): 449-452.
[9]
9. Shawon MS, Perret JL, Senaratna CV, et al. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Sleep Med Rev, 2017, 32: 58-68.
13. Marin JM, Soriano JB, Carrizo SJ, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med, 2010, 182(3): 325-331.
22. Kuklisova Z, Tkacova R, Joppa P, et al. Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome. Sleep Med, 2017, 30: 139-145.
[23]
23. Stanchina M. Is hyperinflation from chronic obstructive pulmonary disease " protective” of upper airway collapse in obstructive sleep apnea?. Ann Am Thorac Soc, 2016, 13(7): 1012-1013.
[24]
24. Van de Graaff WB. Thoracic influence on upper airway patency. J Appl Physiol, 1988, 65: 2124-2131.
[25]
25. Squier SB, Patil SP, Schneider H, et al. Effect of end-expiratory lung volume on upper airway collapsibility in sleeping men and women. J Appl Physiol, 2010, 109(4): 977-985.
[26]
26. Hillman DR, Walsh JH, Maddison KJ, et al. The effect of diaphragm contraction on upper airway collapsibility. J Appl Physiol, 2013, 115(3): 337-345.
[27]
28. Owens RL, Malhotra A, Eckert DJ, et al. The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility. J Appl Physiol, 2010, 108(2): 445-451.
[28]
29. Heinzer RC, Stanchina ML, Malhotra A, et al. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med, 2005, 172(1): 114-117.
[29]
30. Krachman SL, Tiwari R, Vega ME, et al; COPDGene Investigators. Effect of emphysema severity on the apnea-hypopnea index in smokers with obstructive sleep apnea. Ann Am Thorac Soc, 2016, 13(7): 1129-1235.
[30]
27. Heinzer RC, Stanchina ML, Malhotra A, et al. Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea. Thorax, 2006; 61(5): 435-439.
[31]
31. Putcha N, Crainiceanu C, Norato G, et al. Influence of lung function and sleep disordered breathing on all-cause mortality: a community based study. Am J Respir Crit Care Med, 2016, 194(8): 1007-1014.
[32]
32. He BT, Lu G, Xiao SC, et al. Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD. Thorax, 2017, 72(3): 256-262.
[33]
33. Dragonieri S, Porcelli F, Longobardi F, et al. An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea. J Breath Res, 2015, 9(2): 026005.
[34]
34. Santini G, Mores N, Penas A, et al. Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease. Curr Top Med Chem, 2016, 16(14): 1610-1630.
[35]
35. Dragonieri S, Quaranta VN, Carratu P, et al. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study. J Breath Res, 2016, 10(4): 041001.